Salarius Pharmaceuticals Announces 1-For-8 Reverse Stock Split, Will Trade On A Split-Adjusted Basis On June 17, 2024
Portfolio Pulse from Benzinga Newsdesk
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) announced a 1-for-8 reverse stock split effective June 14, 2024. The stock will trade on a split-adjusted basis starting June 17, 2024, under the same symbol 'SLRX' but with a new CUSIP number.
June 12, 2024 | 12:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Salarius Pharmaceuticals is implementing a 1-for-8 reverse stock split effective June 14, 2024. The stock will trade on a split-adjusted basis starting June 17, 2024.
Reverse stock splits are often used to increase the per-share price of a company's stock. While this does not change the company's market capitalization, it can affect investor perception and trading behavior. The neutral score reflects the uncertainty in short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100